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Regulation of the rat liver sodium-dependent bile acid
cotransporter gene by prolactin. Mediation of transcriptional
activation by Stat5.
T C Ganguly, … , F J Suchy, M Vore
J Clin Invest. 1997;99(12):2906-2914. https://doi.org/10.1172/JCI119485.
The intracellular mechanism(s) underlying the upregulation of the hepatic Na+/taurocholate cotransporting polypeptide
(ntcp) by prolactin (PRL) are unknown. In this report, we demonstrate a time-dependent increase in nuclear translocation
of phosphorylated liver Stat5 (a member of the ignal ransducers and ctivators of ranscription family) that correlated with
suckling-induced increases in serum PRL levels. In electrophoretic mobility gel shift assays, nuclear Stat5 exhibited
specific DNA-binding ability towards IFN-gamma-activated sequence (GAS)-like elements (GLEs; 5'TTC/A-PyNPu-
G/TAA-3') located in the -937 to -904 bp region of the ntcp promoter. Transient cotransfections in HepG2 cells revealed
that PRL inducibility (2.5-3-fold) required coexpression of the long form of the PRL receptor (PRLRL) and Stat5. Deletion
analysis mapped the PRLinducible region to -1237 to -758 bp of the ntcp promoter. Linking this 0.5-kb region to a
heterologous thymidine kinase (tk) promoter, or linking multimerized ntcp GLEs either upstream of the ntcp minimal
promoter (-158 to +47 bp) or the heterologous promoter conferred dose-dependent PRL responsiveness. The short form
of the PRL receptor failed to transactivate ntcp GLEs. These results indicate that PRL acts via the PRLRL to facilitate
Stat5 binding to ntcp-GLEs and to transcriptionally regulate ntcp.
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The intracellular mechanism(s) underlying the upregula-





peptide (ntcp) by prolactin (PRL) are unknown. In this re-
port, we demonstrate a time-dependent increase in nuclear
translocation of phosphorylated liver Stat5 (a member of the
Signal Transducers and Activators of Transcription family)
that correlated with suckling-induced increases in serum
PRL levels. In electrophoretic mobility gel shift assays, nu-
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Linking this 0.5-kb region to a heterologous thymidine ki-


















bp) or the heterologous promoter conferred dose-dependent
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A critical function of the mammalian liver is the formation and
maintenance of bile flow. The major driving force for bile se-
cretion is provided by the vectorial active transport of osmoti-
cally active agents (primarily bile salts) in a concentrative man-
ner into the confined space of the canaliculus, followed by the
passive movement of water and counter ions until osmotic





cotransport of bile salts, such as taurocholate, across the baso-




75–80% of total bile salt up-
take, and is the first step in transcellular movement across the









 has been cloned
(2), and its expression in COS-7 cells has been shown to confer
transport characteristics similar to those observed in vivo (3).











cholate cotransport is increased in hepatocytes from postpar-
tum rats compared to nonpregnant and pregnant rats (4). This
increase is blocked by inhibition of secretion of the anterior pi-
tuitary hormone PRL, and is mimicked by infusion of oPRL in





rocholate cotransporter activity is also observed in highly puri-
fied basolateral membrane vesicles from postpartum rats, and




 mRNA and immunodetectable ntcp protein (5–8). De-
spite these advances, the intracellular mechanism(s) leading to




 transcription are largely un-
known. However, the female rat liver is known to contain a
significant number of PRL receptors (9), suggesting the role of
a receptor-mediated event. The two isoforms of the hepatic









members of the cytokine/hematopoietin/growth factor recep-
tor superfamily (10). Although both forms of the receptor bind









 lacks the signaling





 serves as a transporter or a binding protein to
convey PRL from one cellular compartment to another (11).
Recently, the signal transduction mechanism of PRL has
been studied using in vitro cell culture systems and mammary





sequential receptor dimerization leading to the activation of an
associated cytoplasmic tyrosine kinase, Jak-2 (a member of the
Janus kinase family), which then phosphorylates a single ty-




 (12–17). The phos-




 recruits a latent transcription
factor, Stat5 (a member of the Signal Transducers and Activa-
tors of Transcription family of transcription factors). Stat5 is in
turn activated by Jak-2 via phosphorylation on a single ty-
rosine residue located at position 694 (18, 19). The phosphory-
lated Stat5 proteins form dimers that are released into the cy-
toplasm and translocated to the nucleus, where they bind
to specific DNA sequences and activate transcription of PRL-
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–activated sequence (GAS)-like elements; HSVtk, herpes simplex














, short form of PRL receptor; Stat, signal trans-
ducers and activators of transcription.
 
 




responsive genes, such as the casein gene (20, and references
therein).








flanking region has facilitated investigations of molecular
mechanisms involving its hormonal regulation. It appears that
a TATA element, a binding element for a yet-unknown liver-





158 bp upstream of the transcription start site,
























 Two such putative binding sites, corresponding to
Stat5 consensus binding motifs TTC/A PyNPu G/TAA, were
identified by sequence homology searches (21, 22). These pal-
indromic sequences were initially identified in the mammary





activated sequence (GAS)-like elements (GLEs). These se-





genes of various species and other genes, such as the serine
protease inhibitor-3 (SPI-3) and insulin-1 gene (23, 24). Addi-
tionally, several reports have elegantly demonstrated the pres-
ence of Stat5 protein in the rat liver nuclei late in an acute
phase response (25) or after treatment with growth hormone
(GH; 26, 27). Taken together, these observations led to our
working hypothesis that in the postpartum period, high levels




 transcription via a ty-
rosine phosphorylation signaling pathway that involves the he-
patic PRL receptor(s) and Stat5. The present studies were




) PRL activates Stat5




) Stat5 exhibits specific binding






















All reagents were of molecular biology or
cell culture grade. Restriction enzymes and polynucleotide kinase
were obtained from GIBCO BRL (Gaithersburg, MD). Ovine PRL
(oPRL, NIDDK-oPRL-19; AFP-9221-A) was kindly provided by the
National Institute of Diabetes and Digestive and Kidney Diseases,
National Hormone and Pituitary Program, National Institute for
Child Health and Human Development, and the US Department of
Agriculture. Antibodies used in this study were Stat5 mAb (raised
against ovine Stat5 amino acids 451–469; Transduction Laboratories,
Lexington, KY), polyclonal rabbit anti–mouse Stat5b (raised against
amino acids 711–727 of the carboxy terminus of mouse Stat5b), phos-
photyrosine (PY-20) antibody agarose conjugate (Santa Cruz Biotech
Inc., Santa Cruz, CA), phosphotyrosine (4G10) mAb (Upstate Biotech-
nologies Inc., Lake Placid, NY), and anti–mouse and anti–rabbit IgG




Pregnant Sprague-Dawley rats (Harlan Industries, In-
dianapolis, IN) timed at the first day that sperm were detected (day 0)
were housed in cages with Sani-chips bedding (PJ Murphy Forest
Products, Montville, NJ). The rats had free access to Agway Prolab-
3000 rat chow (Charlotte, NC) and water, and were maintained on a
14-h, automatically timed light and dark cycles (lights on at 6:00 a.m.,
off at 8:00 p.m.) in a HEPA-filtered laminar flow unit for at least 7 d
before use. Litter sizes were culled to eight pups. Pups, 4–5 d post
partum, were removed from the dams overnight to decrease maternal
serum PRL levels. The pups were returned to the dams and allowed
to suckle for 0, 15, 30, or 60 minutes before killing of the dam by de-
capitation and removal of the maternal liver for preparation of nu-




Blood was collected after decapitation, and
serum was isolated by centrifugation for measurement of PRL levels




Rat liver nuclear extracts were pre-
pared by the method of Standke et al. (29) with the inclusion of phos-









) along with the protease inhibitors antipain,













g/ml); and 0.1 mM
PMSF in the homogenization buffer. After extraction in high salt









, 10% glycerol, 1 mM DTT, and 0.1 mM PMSF), the extracts
were dialyzed (for 90 min) in 250 ml of buffer containing 10 mM









erol, 1 mM DTT, and 0.1 mM PMSF. The precipitate formed during




 for 5 min, after









C. Protein concentrations were measured by the
method of Lowry (30) using BSA as standard.
 











g of PY-20 mAb aga-









immunoprecipitation buffer (1% Triton X, 150 mM NaCl, 10 mM













g/ml of pepstatin, aprotinin, and leu-









l of a 50% suspension of Sepharose 6MB beads (Pharma-
cia Biotech, Uppsala, Sweden) was added to the samples that were
immunoprecipitated with the 4G10 antibody and mixed for an addi-
tional hour. The immunoprecipitated proteins bound to agarose con-
jugates or beads were pelleted and washed three times with immuno-








 SDS sample buffer




-mercaptoethanol, 2% glycerol, 200 mM Tris/HCl





protein or immunoprecipitated proteins were resolved on an 8.5%
SDS-PAGE, and the proteins were transferred to nitrocellulose
membrane. Transfer was assessed by incubating with 0.1% Ponceau,
and standards were marked. The membrane was washed with distilled





wash buffer (100 mM NaCl, 1% Tween 20, 10 mM Tris/HCl, pH 7.5)
containing 3% BSA (Fraction V; Sigma, St. Louis, MO) and then
incubated for 1 h with primary antibodies (1:3,000 dilution of either
monoclonal Stat5, monoclonal phosphotyrosine 4G10 antibody, or
polyclonal anti–rabbit Stat5b) in wash buffer containing 3% BSA. Af-
ter six washes (5 min each), the membranes were incubated with anti–
mouse IgG horseradish peroxidase conjugate (1:3,000) or anti–rabbit
IgG horseradish peroxidase conjugate (1:5,000) for 1 h. After another
six washes, the proteins were visualized using the enhanced chemilu-
minescence detection system (Amersham). Blots were stripped for
30 min in buffer containing 62.5 mM Tris-HCl (pH 6.8), 2% SDS,

















 was kindly pro-





-galactosidase and the cytomegalovirus-driven mam-
malian expression vector pL3T7CMV were generously provided by
Dr. Daniel Noonan and Kenneth W. Henry II (University of Ken-
tucky). The cDNAs for the long and short form of the rat prolactin
receptors (clones R2 and F3, respectively) were gifts from Dr. Paul
Kelly (INSERM, Paris, France). Ovine Stat5 cDNA (pXM-MGF)
was a generous gift from Dr. Bernd Groner (Institute for Experimen-










 was similarly constructed by subcloning the
1.6-kb EcoRI-EcoRI fragment of clone F3 to pL3T7CMV. Fig. 1 is a






the study. The construction of p-1237Luc, p-758Luc, and p-158Luc were
described previously (21). 0.2pGL3 was constructed by ligating the
200-bp HindIII fragment obtained by digesting p-158Luc at the
HindIII site of pGL3 basic vector (Promega, Madison, WI). 0.5pT109-












 upstream of the herpes simplex virus thymi-
dine kinase minimal promoter (HSVtk) in pT109Luc (American
Type Culture Collection, Rockville, MD). To create the plasmids



































 ends were concatenated
to obtain two and four tandem GLEs that were then ligated to the
HindIII-digested pT109Luc plasmid. 2X0.2pGL3 and 4X0.2pGL3
were created by ligating the KpnI–BamHI digest of 2XpT109Luc and













in p0.2GL3. The orientation and integrity of all plasmids were veri-
fied by sequencing (31) using specific primers by Sequenase kit (U.S.
Biochemical, Cleveland OH) or the Thermosequenase cycle sequenc-
ing kit (Amersham).
 
Electrophoretic mobility shift assays.
 
The following double-stranded
oligonucleotides were used (sense strand sequence; Stat-binding sites

























), a 21 mer containing the bovine b-casein Stat5 consensus binding
motif (59-agatTTCTAGGAAttcaatcc-39), mutant Stat5 (59-agat-
TTAGTTTAAttcaatcc-39, sense strand sequence identical to consen-
sus Stat5 except for the ctagg → agttt substitution in the Stat5-binding
motif) and glucocorticoid response element oligonucleotide (59-tcg-
actgtacaggatgttctagctact-39). The probes (50,000 cpm/ng) were 32P-
radiolabeled with [g32P]ATP, using polynucleotide kinase at the 59OH
blunt ends. The end-labeled, double-stranded oligos were gel purified
from free ATP and single-stranded oligos on a 12% polyacrylamide
gel, excised and eluted in 13 NET buffer (0.1 M NaCl, 1 mM
EDTA, and 1 mM Tris-HCl [pH 7.6]). Electrophoretic mobility shift
assays were conducted essentially as described (32). Nuclear extracts
(5 mg protein) were incubated for 20 min at room temperature with
10 fmol of purified probe in a 20-ml reaction containing 5 mM Tris-
HCl [pH 7.9], 15 mM Hepes-KOH [pH 7.9], 0.08 M KCl, 3.5 mM
MgCl2, 5 mM EDTA, 5 mM DTT, 10% glycerol, 0.1% Tween 20, and
0.133 mg/ml poly (dI-dC):poly (dI-dC). Free probe and protein-
bound probe were separated on a 4% polyacrylamide gel containing
2.5% glycerol and 0.253 TBE (25 mM Tris-HCl, 25 mM boric acid,
and 0.25 mM EDTA [pH 8]). The gel was dried and exposed to
autoradiography at 2808C. In competition assays, 100 and 500 fmol
(10- and 50-fold molar excess) of the specific unlabeled oligo was
added to the binding reaction. In supershift studies, nuclear extracts
were preincubated at 48C for 15 min, followed by 30 min at room tem-
perature with 1 ml (1 mg/ml) of Stat5 polyclonal antibody before the
addition of labeled oligo. In certain cases, the free probe was allowed
to run off the gel to better visualize the DNA–protein complexes.
Transient transfections. HepG2 cells were maintained in DMEM/
F12-Ham’s (50:50) medium supplemented with 10% FBS (GIBCO
BRL), 55 mg/ml gentamicin (Sigma), 3.58 mM glutamine, and 1 mg/ml
insulin (GIBCO BRL). 1 d before transfection, cells were plated in
phenol red–free DMEM containing 10% charcoal stripped serum
(Hyclone Laboratories, Logan, UT) at 70% confluency. Transfections
were done using recombinant plasmid DNA that was purified twice
through cesium chloride gradient. Briefly, cells were transfected with
5 mg of luciferase constructs, 5 mg of pXM-MGF, and 1 mg of pL3-
PRLRL or pL3-PRLRS and pUC19 as carrier to a total of 20 mg/10-cm
plate using the calcium phosphate/DNA coprecipitation method (33).
5 mg of pRSV-b-galactosidase was included in each transfection to
monitor transfection efficiency. Medium was removed 6–8 h after
transfection, and the cells were washed twice with PBS and replated
(30,000 cell/well) in a 96-well plate. Treatment was either in the ab-
sence or with seven incremental concentrations of oPRL (0.01, 0.05,
0.1, 0.5, 1, 5, and 10 mg/ml). After 36–40 h, the cells were washed with
PBS and lysed in 50 ml of lysis buffer (25 mM Tris-phosphate [pH 7.8],
15% glycerol, 2% Chaps, 1% lecithin, 1% BSA, 4 mM EGTA, 8 mM
MgCl2, 1 mM DTT and 0.4 mM PMSF). Cell extract (20 ml) was com-
bined with 100 ml K-ATP/MgCl2 buffer (100 mM K-phosphate, 3.65
mM ATP, 1 M MgCl2, and 50 mM Tris-HCl [pH 7.8]) and assayed for
luciferase activity using a luminometer (Dynatech Laboratories,
Chantilly, VA). The remaining cell extract was mixed with 200 ml of
o-nitrophenyl b-galactopyranoside (ONPG) substrate solution (100
mM NaH2PO4 [pH 7.8], 6.64 mM ONPG) and analyzed for b-galac-
tosidase activity at 415 nm on an ELISA plate reader (Bio Rad Labo-
ratories). Normalized luciferase response was then calculated as rela-
tive light units divided by b-galactosidase activity (OD415 nm per
Figure 1. Structures of the plasmid constructs of the rat ntcp pro-
moter used in transfections. The two GLEs are located between 2936 
and 2904 bp in the rat ntcp promoter sequence. The 2158 to 147 re-
gion constitutes the minimal rat ntcp promoter, and synthetic oligo 
nucleotides containing two or four GLEs (shown in parentheses) 
were fused to either the minimal promoter in the plasmid pGL3 or 
the heterologous thymidine kinase minimal promoter in pT109Luc to 
obtain the 2X and 4X constructs.
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minute). Each data point generated represents a mean of triplicate
measurements of a single transfection experiment. The oPRL-depen-
dent fold induction (reported relative to normalized luciferase activ-
ity obtained in the absence of oPRL) is reported as mean6SD for at
least three independent transfections.
Results
Increased nuclear translocation of a phosphorylated Stat5-like
protein in postpartum suckling rat liver. In the postpartum rat,
suckling stimulates secretion of PRL by the anterior pituitary,
whereas withdrawl of suckling pups results in decline of serum
PRL levels. The effects of rat PRL on hepatic phosphorylated
Stat5 levels in vivo were investigated by quantifying nuclear
Stat5 levels in the maternal livers in reponse to withdrawal and
subsequent reintroduction of suckling.
Hepatic nuclear extracts from nonsuckling or those ob-
tained from postsuckling rats were subjected to immunoblot
analysis. The blot was probed with an anti-Stat5 mAb, and a
protein of z 95 kD that is immunogenically similar to Stat5
was quantitatively increased in a time-dependent manner in
the post-suckling samples (Fig. 2 A). A parallel blot that was
sequentially treated under identical conditions but probed
with the secondary antibody (anti–mouse IgG horseradish per-
oxidase conjugate) alone revealed nonspecific bands (data not
shown). Phosphorylation status determined in the same sam-
ples using the antiphosphotyrosine mAb (4G10) indicated that
the z 95-kD protein was tyrosine phosphorylated (Fig. 2 B).
To further confirm that the z 95-kD Stat5-like protein was
tyrosine phosphorylated, nuclear extracts were immunoprecip-
itated with the monoclonal antiphosphotyrosine antibody PY-
20 and revealed by Western blotting (Fig. 3 A) using the poly-
clonal Stat5 antibody, respectively. As before, the z 95-kD
band was predominantly detected in the nuclear extracts in the
30- and 60-min samples. Similar results were also obtained
when the antiphosphotyrosine 4G10 was used for immunopre-
cipitation of tyrosine-phosphorylated proteins and the mono-
clonal Stat5 antibody was used for detection of Stat5 (data not
Figure 2. Western blotting of hepatic nuclear proteins from nonsuck-
ling and postsuckling rats. (A) Nuclear extracts (20 mg) from non-
suckling (NS, lanes 1 and 2) or postsuckling 15 min (lanes 3 and 4),
30 min (lanes 5 and 6), and 60 min (lanes 7 and 8), rats were probed 
with anti-Stat5 mAb. (B) The same blot was stripped and probed with 
the monoclonal antiphosphotyrosine antibody, 4G10. Each lane rep-
resents nuclear extracts from an individual animal. Similar results 
were obtained with three to four animals in each group.
Figure 3. (A) Immunoprecipitation of tyrosine phosphorylated Stat5 
protein. Representative nuclear extracts (50 mg) from nonsuckling 
(NS, lane 1) or postsuckling 15 min (lane 2), 30 min (lane 3) and 60 
min (lane 4) rats were immunoprecipitated with the antiphosphoty-
rosine antibody PY-20 and probed with polyclonal rabbit anti-Stat5 
as described in Methods. (B) Serum PRL levels. PRL levels from 
nonsuckling (NS) and 15, 30, and 60 min postsuckling (PS) rats were 
analyzed by a double-antibody RIA (28). Data are expressed as 
mean6SEM for n 5 3–4 rats. *P , 0.05.
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shown). The appearance of the hepatic Stat5-like phosphory-
lated protein in postsuckling rats correlated with increased se-
rum PRL levels (Fig. 3 B), further suggesting that during lac-
tation, the level of nuclear phosphorylated Stat5 is closely
controlled in vivo through signals of circulating PRL which is
in turn induced by the suckling stimulus from the pups.
Phosphorylated Stat5-like factor in nuclear extracts binds to
GAS-like element from the ntcp promoter. To determine if the
Stat5-like protein identified in postsuckling liver nuclear ex-
tracts exhibits DNA-binding ability, an oligo (21 mer) from the
bovine b-casein promoter containing the Stat5 consensus bind-
ing sequence was initially used in gel shift assays (Fig. 4). A
slower migrating gel shift complex was observed only in 30-
and 60-min postsuckling samples. In competition assays, 10-
and 50-fold excess of the unlabeled bovine b-casein consensus
Stat5 oligo or a 29 mer corresponding to 2922/2892 of the
ntcp promoter encompassing the GLE binding motif competi-
tively decreased specific binding. In contrast, both 10- and 50-
fold excesses of unlabeled, mutated Stat5 oligo were unable to
compete for specific binding, indicating strict requirements of
the nuclear protein for the Stat5 cognate binding site. In addi-
tion, the DNA–protein complex was supershifted with poly-
clonal Stat5 antibody, indicating that the nuclear protein that
is detected in a time-dependent manner after suckling is phos-
phorylated Stat5. 
Two GLEs located at positions 2936 to 2928 bp (TTC
CTA GAA) and 2912 to 2904 bp (TTC TTG GAA) were
identified in the ntcp promoter by a sequence homology
search. Both the GLEs match the consensus GAS-binding site
(TTC/A C/TNG/A G/TAA). Furthermore, the nucleotide se-
quence of the GLE located at 2912 to 2904 is identical to the
GAS-binding site found in the promoter of the rat b-casein
gene at all nine nucleotide positions (20, 21). Therefore, a 29
mer containing the ntcp GLE located 2912 to 2904 within its
core was next evaluated for its ability to bind to nuclear pro-
teins. As shown in Fig. 5, three DNA–protein complexes were
observed. The slowest migrating complex (I) was competi-
tively inhibited by 503 molar excess of unlabeled Ntcp oligo
and the consensus Stat5 oligo, but not by a nonspecific gluco-
corticoid response element oligo. Furthermore, this complex
was partially supershifted with polyclonal Stat5 antibody, con-
firming the presence of Stat5 nuclear protein. The identity of
the intermediate migrating complex (II) is unknown, although
it appears to result from a specific interaction, as binding was
decreased by molar excesses of both the competing Ntcp and
consensus Stat5 oligos. The fastest migrating complex (III) was
unchanged among the various groups, and probably results
from a nonspecific DNA–protein interaction. Band shifts with
an oligo encompassing the GLE in 2936 to 2928 of the ntcp
promoter showed a similar pattern of DNA–protein complex
formation as that of the 2912 to 2904 oligo (data not shown).
These data indicate that nuclear Stat5 exhibits specific DNA-
binding ability towards the GLEs in the ntcp promoter.
PRL-dependent transcriptional activation of the ntcp pro-
moter in HepG2 cells. To determine if the ntcp promoter is
PRL responsive, HepG2 cells were transiently transfected with
the plasmid p-1237Luc or vector pSVoALD59, and were
Figure 4. Electrophoretic mobility shift assays. Representative nu-
clear extracts (5 mg) from nonsuckling (NS, lane 1) or postsuckling 
(15, 30, and 60 min, lanes 2–4) rats were used in band shift assays with 
32P-labeled Stat5 consensus oligonucleotide (59-agatTTCTAGGAA-
ttcaatcc-39) as a probe. In competition assays (lanes 5–10), nuclear ex-
tracts from 60-min postsuckling rats were used. 10- and 50-fold molar 
excess of unlabeled Stat5 consensus (Stat5, lanes 5 and 6), ntcp (Ntcp, 
lanes 7 and 8) and mutant Stat5 (MStat, lanes 9 and 10) oligos were 
used in competition assays. Polyclonal rabbit anti-Stat5 (1 mg) was 
used for the supershift assay (lane 11). The same results were repro-
duced with nuclear extracts from independent animals (three to four 
in each group).
Figure 5. Electrophoretic mobility shift assays. Band shift assays 
were performed using 32P-labeled Ntcp oligo (59-gaagttgtcaTTCTTG-
GAAaaataacaat-39) as a probe. The labeled oligo was incubated 
without nuclear extract (lane 1), or with representative nuclear ex-
tracts (5 mg) from nonsuckling (NS, lane 2) or postsuckling (30 and 60 
min, lanes 3 and 4) rats. In competition assays (lanes 5–7), nuclear ex-
tract from 60 min postsuckling rats were used. 50-fold molar excess of 
unlabeled Stat5 consensus (St, lane 5), Ntcp (Nt, lane 6), and gluco-
corticoid response element (G, lane 7) oligos were used in competi-
tion assays. Polyclonal rabbit anti-Stat5 (1 mg) was used for the super-
shift assay (lane 8). The same results were reproduced with nuclear 
extracts from independent animals (three to four in each group).
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treated with varying doses of oPRL. Consistent with earlier re-
ports (21), negligible luciferase activity was observed with
pSVoALD59. Significant levels of luciferase activity were ob-
served in cells transfected with the plasmid p-1237Luc, but no
PRL inducibility was observed, consistent with earlier reports
that HepG2 cells lack either functional PRLRL, Stat5, or
both (29).
Expression vectors containing cDNAs for the PRLRL and
Stat5 were cotransfected with the plasmid p-1237Luc or
pSVoALD59. As shown in Fig. 6 A, addition of oPRL increased
luciferase activity in a dose-dependent manner (2.5- to 3-fold)
only when both the PRLRL and Stat5 cDNAs were cotrans-
fected with p-1237Luc. In comparison, transfection of PRLRL
and Stat5 cDNAs had no effect on the luciferase activity of
pSVoALD59. Exclusion of either the PRLRL or Stat5 expres-
sion vectors abrogated the PRL induction, indicating that the
oPRL response is mediated by the PRLRL via activation of
Stat5.
In cotransfection experiments using deletion constructs
of the ntcp promoter, the plasmids p-758Luc and p-158Luc,
which exhibited significant levels of basal transcription, failed
to respond to oPRL treatment when compared to the plasmid
p-1237Luc (Fig. 6 B). These results support the notion that al-
though the regulatory elements necessary for basal ntcp pro-
moter activity are included in the fragment 2158 to 147, ele-
ments located in the region between 21237 and 2758 bp,
possibly the two GLEs, are required for PRL responsiveness
of the ntcp promoter.
To further delineate the role of these GLEs in mediating
PRL responsiveness, two and four multimerized GLEs were
Figure 6. (A) PRLRL and Stat5 mediate PRL inducibility of the ntcp 
promoter. HepG2 cells were transfected as described in Methods 
with the p-1237Luc construct either alone or cotransfected with the 
expression vectors for the PRLRL and/or Stat5. Luciferase activity 
and b-galactosidase activities were measured in cellular extracts
36–40 after treatments with oPRL. (B) oPRL dose–response curve of 
ntcp promoter deletion constructs. HepG2 cells were cotransfected 
with the appropriate promoter–luciferase plasmid constructs, pRSV-
b-galactosidase, and expression plasmids for PRLRL and Stat5, and 
were treated with the indicated concentration of oPRL. All data are 
expressed as mean6SD of three independent transfections.
Figure 7. (A) GLEs confer PRL responsiveness to ntcp minimal 
promoter. HepG2 cells were cotransfected with the appropriate pro-
moter–luciferase plasmid constructs, pRSV-b-galactosidase, and ex-
pression plasmids for PRLRL or PRLRS and Stat5. oPRL dose–
response curves were generated as described in Methods. (B) ntcp 
GLEs confer PRL responsiveness to heterologous thymidine kinase 
promoter. HepG2 cells were cotransfected with the appropriate pro-
moter–luciferase plasmid constructs, pRSV-b-galactosidase, and ex-
pression plasmids for PRLRL or PRLRS and Stat5. oPRL dose–
response curves were generated as described in Methods. Data are 
expressed as mean6SD of three to four independent transfections.
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inserted upstream of the ntcp minimal promoter in p0.2GL3 to
create the plasmids 2Xp0.2GL3 and 4Xp0.2GL3. As shown in
Fig. 7, A and B, the 2X and 4X GLEs were able to confer
PRL-dependent increases in luciferase activity to the ntcp min-
imal promoter of z 15- and 150-fold higher than 0.2pGL3, re-
spectively. These data indicate that the two GLEs are both
necessary and sufficient for PRL inducibility. Additionally, the
PRLRS failed to transactivate ntcp GLEs in the 4X0.2pGL3
construct, presumably because it is unable to activate Stat5
(Fig. 7 B).
In additional experiments, the ability of the 21237 to 2758
bp region to modulate heterologous promoter activity was ex-
amined. Linking of this 0.5-kb PRL-responsive region up-
stream of the HSVtk promoter in the plasmid pT109Luc (Fig.
7 A) produced a dose-dependent increase in luciferase activity
in response to oPRL stimulation. Furthermore, multimerized
GLEs placed upstream of the HSVtk promoter (2XpT109Luc
and 4XpT109Luc contructs) were also able to confer PRL re-
sponsiveness with the 2X construct showing a similar inducibil-
ity compared to the 0.5-kb construct (z 20-fold higher than
pT109Luc). As observed with the 4X0.2pGL3 construct, the
inclusion of two additional GLEs (4XpT109Luc) had a syner-
gistic effect on luciferase activity (z 100-fold higher activity
than pT109Luc). These results indicate that ntcp GLEs are ca-
pable of transactivating a heterologous promoter and function-
ing as enhancer elements that modulate the activity of the min-
imal ntcp promoter.
Discussion
The present studies establish for the first time the mecha-
nism(s) by which the hormone PRL upregulates hepatic bile
salt transporter function postpartum; namely by activation of
the latent transcription factor Stat5 via the PRLRL. These
studies demonstrate striking similarities in the PRL signaling
pathways in the rat mammary gland and liver that lead to tis-
sue-specific gene expression of two target genes, namely the
b-casein in the mammary gland and ntcp in the liver. As with
the mammary gland, PRL activates Stat5 via PRLRL, presum-
ably by a Jak2-dependent phosphorylation pathway. Interac-
tion of SH2 domains of dimerizing Stat5 partners then confers
the ability to bind to the GLEs in the ntcp promoter and tran-
scriptionally activate the ntcp after translocation of Stat5 mul-
timers to the nucleus. These data, together with earlier reports
(4–8), therefore support the hypothesis that during the post-
partum period, the stimulatory effects of PRL on Na1/tauro-
cholate cotransport across the basolateral membrane of the
hepatocyte appears to be primarily caused by increased tran-
scription of ntcp.
Using a postpartum rat model, we were able to demon-
strate a time-dependent nuclear accumulation of Stat5 that
correlated with serum PRL levels. These data suggest that the
level of phosphorylated Stat5 in vivo is controlled through sig-
nals of circulating PRL that are induced by suckling of the
pups. Waxman et al., have reported that the administration of
GH, but not PRL, in vivo results in nuclear translocation of
Stat5 in the liver (26, 27). The lack of effect of PRL probably
results from the use of hypophysectomized animals by these
researchers, a model in which the hepatic lactogenic receptors
are rapidly downregulated (34, 35). However, preliminary re-
ports have suggested that ntcp is expressed in a sexually dimor-
phic pattern that may be attributed to the pulsatile nature of
GH secretion in male rats (36). Whether GH, which has been
reported to activate multiple Stat proteins, including Stat5,
regulates ntcp transcription by a similar mechanism as PRL is
currently being investigated by this laboratory.
Gel mobility shifts and oligonucleotide competition assays
showed that Stat5 in hepatic nuclear extracts from lactating an-
imals was able to bind with similar specificities to the GAS in
the bovine b-casein promoter (Fig. 4) as well as to the GLE lo-
cated at position 2912 to 2904 of the ntcp promoter (Fig. 5).
Some of the additional protein complexes formed with the
Ntcp oligos, when compared to those formed by the bovine
b-casein oligo, result in part from differences in the sizes of the
two oligos and/or neighboring nucleotide sequences around
the Stat5-binding site. This is supported by the observation
that the core DNA-binding sequences between the GAS sites
in the bovine b-casein (TTCTAGGAA) and ntcp (TTCTTG-
GAA) only differ at a single position. However, the fact that a
single protein complex formed with the bovine b-casein oligo
supershifts with specific anti-Stat5 antibody indicates that
Stat5 homodimers participate in DNA–protein complex for-
mation. At this point we cannot determine whether the com-
plex is composed of Stat5a, Stat5b homo or hetero dimers
since the anti-Stat5 polyclonal antibody used was raised against a
peptide corresponding to the carboxy terminus of mouse
Stat5b, which differs from the corresponding sequence of
Stat5a by only three amino acids. However, this antibody is re-
ported not to cross-react with other members of the Stat fam-
ily, thereby ruling out the participation of heterodimers of
Stat5 and other PRL-activated Stat proteins (namely Stat1 and
Stat3) in the DNA–protein complex formation (37).
We studied the mechanisms involved in PRL responsive-
ness of the ntcp promoter activity in transiently transfected
HepG2 cells. A dose-dependent, PRL-induced increase in ntcp
promoter activity was observed only when expression vectors
for Stat5 and PRLRL cDNA were cotransfected with ntcp pro-
moter–luciferase reporter constructs. This supports the notion
that PRL-dependent transactivation is a receptor-mediated
event that requires the Stat5 protein. Interestingly, of the two
forms of the PRL receptor present in the female rat liver, the
PRLRS is the predominant form. To date, however, the func-
tional role of the short form of the receptor has not been de-
fined clearly (12, 38). The present studies indicate that the
hepatic PRLRL, not the PRLRS, plays a critical role in modu-
lating bile salt transport across the basolateral domain of the
hepatocyte. The PRLRS originates from alternate splicing of
the PRLR mRNA and is distinguished from the PRLRL by a
truncated carboxy-terminal cytoplasmic domain (39, 40). How-
ever, the juxtamembrane cytoplasmic subdomains named Box 1
(proline rich) and Box 2 (acidic region), which are conserved
structural features of class I cytokine receptors, are present in
both forms of the receptors (41–43). The PRLRS is thus able to
maintain PRL-induced Jak-2 association via the Box 1 subdo-
main (44). However, truncated PRLR variants that lack the
conserved cytoplasmic tyrosine residues are still capable of re-
cruiting Stat1, Stat3, and Stat5 to the activated PRLR complex
via Jak-2 (37). All together, these observations suggest that in
addition to Jak-2 activation, amino acids in the COOH termi-
nus of the PRLRL that are absent in PRLRS are also involved
in Stat recruitment.
By deletion analysis, the PRL-responsive region of the ntcp
promoter was mapped to the two GLEs located within 2937
to 2904 upstream of the transcription start site. Subsequently,
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we demonstrated that the GLEs confer PRL responsiveness to
the ntcp minimal promoter, and are also able to modulate the
activity of a heterologous thymidine kinase promoter. These
data provide strong evidence that the two GLEs in the ntcp
promoter function in PRL-induced transcriptional regulation
of this gene after the binding of Stat5 dimers. The synergistic
effect on reporter gene activity observed with the multiple
GLE constructs is probably caused by cooperative binding of
Stat proteins to several adjacent GAS, which is facilitated by
the amino-terminal domain, as has been recently reported
(44). Whether or not Stat5 plays a principal role in ntcp regula-
tion in the male or the nonlactating female rat liver awaits fur-
ther studies. These experiments also raise an important ques-
tion as to whether ntcp transcription can be modulated by
other cytokines, such as erythropoietin, GM-CSF, and mem-
bers of the IL family that activate Stat5 via their respective re-
ceptors (45).
In summary, the rat liver is an important target organ for
PRL. This hormone has been shown to have diverse biological
effects on cell growth, steroidogenesis, maternal behavior, os-
moregulation, and immune response in various species (11, 46,
47). The present studies establish an additional physiological
role for PRL in the regulation of Na1-dependent bile salt
transporter function during the postpartum period. PRL may
thus play an important role in maternal nutritional status by in-
creasing uptake and biliary secretion of bile salts (4, 28, 48),
which are essential for the absorption of fats and fat-soluble vi-
tamins.
Acknowledgments
The authors express their deepest gratitude to Dr. Daniel Noonan for
unrestricted access to the Dynatech luminometer and data analysis
software. 
This work was supported by National Institutes of Health grants
DK46923 and GM55343 to Mary Vore, DK02318 to Saul Karpen, and
HD 20632 to Fredrick J. Suchy.
References
1. Nathanson, M.H., and J.L. Boyer. 1991. Mechanisms and regulation of
bile secretion. Hepatology. 12:551–556.
2. Hagenbuch, M., B. Stieger, H. Lubbert, and P.J. Meier. 1991. Functional
expression cloning of the hepatocyte Na1/bile acid cotransporter. Proc. Natl.
Acad. Sci. USA. 88:10629–10633.
3. Boyer, J.L., O.C. Ng, M. Ananthanarayanan, A.F. Hofmann, C.D.
Schteingart, B. Hagenbuch, B. Stieger, and P.J. Meier. 1994. Expression and
characterization of a functional rat liver Na1/bile acid cotransport system in
COS-7 cells. Am. J. Physiol. 266:G382–G387.
4. Ganguly, T., J.F. Hyde, and M. Vore. 1993. Prolactin increases Na1/tau-
rocholate cotransport uptake in isolated hepatocytes from postpartum and
ovariectomized rats. J. Pharm. Exp. Therap. 267:82–87.
5. Ganguly, T., Y. Liu, J.F. Hyde, B. Hagenbuch, P. Meier, and M. Vore.
1994. Prolactin increases hepatic Na1/taurocholate cotransport activity and
messenger RNA postpartum. Biochem. J. 303:33–36.
6. Liu, Y., T. Ganguly, J.F. Hyde, B. Hagenbuch, P. Meier, and M. Vore.
1995. Prolactin increases mRNA encoding Na1-taurocholate cotransport poly-
peptide and Na1/taurocholate cotransport. Am. J. Physiol. 31:G11–G17.
7. Liu, Y., B. Stieger, P. Meier, and M. Vore. 1995. Increased Na1/taurocho-
late cotransport in basolateral liver plasma membrane vesicles postpartum is
due to overexpression of Na1/taurocholate cotransport polypeptide. Hepatol-
ogy. 22:319A (Abstr. 852).
8. Vore, M., Y. Liu, and T. Ganguly. 1996. Prolactin and Bile Secretory
Function in Pregnancy, Sex Hormones and the Liver. H.B. Reyes, U. Leusch-
ner, and I.M. Arias, editors. Falk Symposia 89. Kleuver Academic Publishers,
Dordrecht, The Netherlands. 77–83.
9. Jahn, G.A., M. Edery, L. Belair, P.A. Kelly, and J. Djiane. 1991. Prolactin
receptor gene expression in rat mammary gland and liver during pregnancy and
lactation. Endocrinology. 128:2976–2984.
10. Kelly, P.A., J. Djiane, M. Postel-Vinay, and M. Edery. 1991. The prolac-
tin-growth hormone receptor family. Endocrine Rev. 12:235–251.
11. Hooghe, R., M. Delhase, P. Vergani, A. Malur, and E.L. Hooghe-
Peters. 1993. Growth hormone and prolactin are paracrine growth and differ-
entiation factors in the hematopoietic system. Immunol. Today. 14:212–221.
12. Lesueur, L., M. Edery, S. Ali, J. Paly, P.A. Kelly, and J. Djiane. 1991.
Comparison of long and short forms of the prolactin receptor on prolactin-
induced milk protein gene transcription. Proc. Natl. Acad. Sci. USA. 88:824–
828.
13. Rui, H., R.A. Kirken, and W.L. Farrar. 1994. Activation of receptor-
associated tyrosine kinase JAK2 by prolactin. J. Biol. Chem. 269:5364–5367.
14. Campbell, G.S., L.S. Argetsinger, J.N. Ihle, P.A. Kelly, J.A. Rillema,
and C. Carter-Su. 1994. Activation of Jak-2 tyrosine kinase by prolactin recep-
tors in Nb2 cells and mouse mammary gland explants. Proc. Natl. Acad. Sci.
USA. 91:5232–5236.
15. Lebrun, J.-J., S. Ali, V. Goffin, A. Ullrich, and P.A. Kelly. 1995. A single
phosphotyrosine residue of the prolactin receptor is responsible for activation
of gene transcription. Proc. Natl. Acad. Sci. USA. 92:4031–4035.
16. Lebrun, J.-J., S. Ali, L. Sofer, A. Ullrich, and P.A. Kelly. 1994. Prolac-
tin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the
prolactin receptor and its associated tyrosine kinase Jak2. J. Biol. Chem. 269:
14021–14026.
17. Waters, M.J., N. Daneil, C. Bignon, and J. Djiane. 1995. The rabbit
mammary gland prolactin receptor is tyrosine phosphorylated in response to
prolactin in vivo and in vitro. J. Biol. Chem. 270:5136–5143.
18. Wakao, H., F. Gouilleux, and B. Groner. 1994. Mammary gland factor
(MGF) is a novel member of the cytokine regulated transcription factor gene
family and confers the prolactin response. EMBO (Eur. Mol. Biol. Organ.) J.
13:2182–2191.
19. Gouilleux, F., H. Wakao, M. Mundt, and B. Groner. 1994. Prolactin in-
duces phosphorylation of Tyr694 of Stat 5 (MGF), a prerequisite for DNA
binding and induction of transcription. EMBO (Eur. Mol. Biol. Organ.) J. 13:
4361–4369.
20. Groner, B., and F. Gouilleux. 1995. Prolactin-mediated gene activation
in mammary epithelial cells. Curr. Opin. Gen. & Dev. 5:587–594.
21. Karpen, S.J., A.-Q. Sun, B. Kudish, B. Hagenbuch, P.J. Meier, M. Anan-
thanarayanan, and F.J. Suchy. 1996. Multiple factors regulate the rat liver baso-
lateral sodium-dependent bile acid cotransporter gene promoter. J. Biol. Chem.
271:15211–15221.
22. Horseman, N.D., and L.-Y. Yu-Lee. 1994. Transcriptional regulation by
helix bundle peptide hormones: growth hormone, prolactin and hematopoietic
cytokines. Endocrinol. Rev. 15:627–664.
23. Kordula, T., J. Ripperger, K. Morella, J. Travis, and H. Baumann. 1996.
Two separate signal transducer and activator of transcription proteins regulate
transcription of the serine proteinase inhibitor-3 gene in hepatic cells. J. Biol.
Chem. 271:6752–6757.
24. Galsgaard, E.D., F. Gouilleux, B. Groner, P. Serup, J.H. Neilson, and N.
Billestrup. 1996. Identification of a growth hormone-responsive Stat5-binding
element in the rat insulin 1 gene. Mol. Endocrinol. 10:652–660.
25. Ripperger, J.A., S. Fritz, K. Richter, G.M. Hocke, F. Lottspeich, and
G.H. Fey. 1995. Transcription factors Stat3 and Stat5b are present in rat liver
nulei late in an acute phase response and bind to interleukin-6 response ele-
ments. J. Biol. Chem. 270:29998–30006.
26. Waxman, D.J., R.A. Ram, S.-H. Park, and H.K. Choi. Intermittent
plasma growth hormone triggers tyrosine phosphorylation and nuclear translo-
cation of a liver-expressed, Stat 5-related DNA binding protein. J. Biol. Chem.
270:13262–13270.
27. Ram, P.A., S.-H. Park, H.K. Choi, and D.J. Waxman. 1996. Growth hor-
mone activation of Stat1, Stat3, and Stat5 in rat liver: differential kinetics of
hormone desensitization and growth hormone stimulation of both tyrosine
phosphorylation and serine/threonine phosphorylation. J. Biol. Chem. 271:
5929–5940.
28. Liu, Y., J.F. Hyde, and M. Vore. 1992. Prolactin regulates maternal bile
secretory function postpartum. J. Pharmacol. Exp. Ther. 261:560–566.
29. Standke, G.J.R., V.S. Meier, and B. Groner. 1994. Mammary gland fac-
tor activated by prolactin in mammary epithelial cells and acute-phase response
factor activated by interleukin-6 in liver cells share DNA binding and transacti-
vation potential. Mol. Endocrinol. 8:469–477.
30. Lowry, O.H., N.J. Rosenbrough, A.J. Farr, and R.J. Randall. 1951. Pro-
tein measurement with folin phenol. J. Biol. Chem. 193:265–275.
31. Sanger, F., S. Nicklen, and A.R. Coulson. 1977. DNA sequencing with
chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:5463–5467.
32. Chodosh, L.A. Mobility shift DNA-binding assay using gel electro-
phoresis. In Current Protocols in Molecular Biology. Ausubel, F.M., R. Brent,
R.E. Kingston, D.D. Moore, J.G. Seidman, J.A. Smith, and K. Struhl, editors.
John Wiley & Sons, New York. 12.2.1–12.2.10.
33. O’Brien, M. S.M. Rangwala, K.W. Henry, C. Weiberger, D.C. Crick,
C.J. Waechter, D.R. Feller, and D.J. Noonan. 1996. Convergence of three ste-
roid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis.
Carcinogenesis. 17:185–190.
34. Kelly, P.A., B.I. Posner, and H.G. Friesen. 1975. Effects of hypophysec-
tomy, ovariectomy and cycloheximide on specific binding sites for lactogenic
2914 Ganguly et al.
hormones in rat liver. Endocrinology. 97:1408–1415.
35. Herrington, A.C., S. Philips, and W.H. Daughday. 1976. Pituitary regu-
lation of human growth hormone binding sites in rat liver membranes. Metabo-
lism. 25:341–353.
36. Bowman, S.B., J. Fortune, E. Sutherland, A. Wolkoff, and F.R. Simon.
1995. Sex differences and hormonal regulation of hepatic organic anion trans-
porters. Hepatology. 22:312A (Abstr. 824).
37. DaSilva, L., H. Rui, R.A. Erwin, O.M. Zack Howard, R.A. Kirken,
M.G. Malabarba, R.H. Hackett, A.C. Larner, and W.L. Farrar. 1996. Prolactin
recruits Stat1, Stat3, Stat5 independent of conserved receptor tyrosines Tyr402,
Tyr479, Tyr515, and Tyr 580. Mol. Cell. Endocrinol. 117:131–140.
38. Boutin, J.M., C. Jolicoeur, H. Okamura, J. Gagnon, M. Edery, M. Shi-
rota, D. Banville, I. Dusanter-Fourt, J. Djiane, and P.A. Kelly. 1988. Cloning
and expression of the rat prolactin receptor, a member of the growth hormone/
prolactin receptor family. Cell. 53:69–77.
39. Shirota, M., D. Banville, S. Ali, C. Jolicoeur, J.M. Boutin, M. Edery, J.
Djiane, and P.A. Kelly. 1990. Expression of two forms of prolactin receptor in
rat ovary and liver. Mol. Endocrinol. 4:1136–1142.
40. Cosman, D. 1993. The hematopoietin receptor superfamily. Cytokine. 5:
95–106.
41. Bazan, F. 1989. A novel family of growth factor receptors: a common
binding domain in the growth hormone, prolactin, erythropoietin and IL-6 re-
ceptors and p75-IL-2 receptor b-chain. Biochem. Biophys. Res. Commun. 164:
788–795.
42. Murakami, M., M. Narazaki, M. Hibi, H. Yawata, K. Yazukawa, M.
Hamaguchi, T. Taga, and T. Kishimoto. 1991. Critical cytoplasmic region of the
IL-6 signal transducer, gp130, is conserved in the cytokine receptor family.
Proc. Natl. Acad. Sci. USA. 88:11349–11353.
43. LeBrun, J., S. Ali, A. Ullrich, and P. Kelly. 1995. Proline-rich sequence-
mediated Jak-2 association to the prolactin receptor is required but not suffi-
cient for signal transduction. J. Biol. Chem. 270:10664–10670.
44. Xu, X., Y.-L. Sun, and T. Hoey. 1996. Cooperative DNA binding and se-
quence-selective recognition conferred by the Stat amino-terminal domain. Sci-
ence (Wash. DC). 273:794–797.
45. Gouilleux, F., C. Pallard, I. Dusanter-Fourt, H. Wakao, L.-A. Haldosen,
G. Norstedt, D. Levy, and B. Groner. 1995. Prolactin, growth hormone, eryth-
ropoietin and granulocyte-macrophage colony stimulating factor induce MGF-
Stat DNA binding activity. EMBO (Eur. Mol. Biol. Organ.) J. 14:2005–2013.
46. Meites, J. 1988. Biological actions of prolactin in mammals. In Prolactin
Gene Family and Its Receptors. K. Hoshino, editor. Excerpta Medica, Amster-
dam. 123–130.
47. Gala, R.R. 1991. Prolactin and growth hormone in the regulation of the
immune system. Proc. Soc. Exp. Biol. 198:513–527.
48. Liu, Y., F.J. Suchy, J.A. Silverman, and M. Vore. 1997. Prolactin in-
creases ATP-dependent taurocholate cotransport in canalicular plasma mem-
brane from rat liver. Am. J. Physiol. 35:G46–G53.
